Cotrimoxazole - optimal dosing in the critically ill

Outcomes of Patients with Melioidosis Treated with Cotrimoxazole Alone for Eradication Therapy

(2012) Sarunyou Chusri et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents

(2012) Michelle L Campbell et al.   ANNALS OF PHARMACOTHERAPY

Susceptibility of 186 Nocardia sp. Isolates to 20 Antimicrobial Agents

(2011) Julián Larruskain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients

(2011) Hideaki Kagaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and characterization of extended-spectrum β-lactamase– and AmpC β-lactamase–producing Escherichia coli: results of the CANWARD 2007–2009 study

(2011) Patricia J. Simner et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

(2011) Gary R. Matzke et al.   KIDNEY INTERNATIONAL

Trimethoprim/Sulfamethoxazole Pharmacokinetics in Two Patients Undergoing Continuous Venovenous Hemodiafiltration

(2010) Ivanka Curkovic et al.   ANNALS OF PHARMACOTHERAPY

Antimicrobial‐ResistantNocardiaIsolates, United States, 1995–2004

(2010) Kristin Broome Uhde et al.   CLINICAL INFECTIOUS DISEASES

Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint

(2010) S. Lemaire et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis

(2010) M.-F. Tripodi et al.   Transplant Infectious Disease

Dosing Regimens of Cotrimoxazole (Trimethoprim-Sulfamethoxazole) for Melioidosis

(2009) A. C. Cheng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: a case report

(2009) Luciana C. Faria et al.   Clinics

Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole

(2009) Karolyn A. Wanat et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Probable Trimethoprim/Sulfamethoxazole–Induced Higher-Level Gait Disorder and Nocturnal Delirium in an Elderly Man

(2008) Lucy E Dakin   ANNALS OF PHARMACOTHERAPY

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES